Arvaya Healthcare
New to Zerodha? Sign-up for free.
New to Zerodha? Sign-up for free.
Get instant stock alerts
- Share Price
- Financials
- Revenue mix
- Shareholdings
- Peers
- Forensics
Share Price
Coming soon
- 5D
- 1M
- 6M
- YTD
- 1Y
- 5Y
- MAX
Financials
-
Summary
-
Profit & Loss
-
Balance sheet
-
Cashflow
This data is currently unavailable for this company.
| (In Cr.) |
|---|
| (In Cr.) | ||||
|---|---|---|---|---|
|
This data is currently unavailable for this company. |
| (In %) |
|---|
| (In Cr.) |
|---|
| Financial Year (In Cr.) |
|---|
Revenue mix
-
Product wise
-
Location wise
Revenue Mix
This data is currently unavailable for this company.
Revenue Mix
This data is currently unavailable for this company.
Forensics
Recent events
-
News
-
Corporate Actions
Arvaya Healthcare Limited’s board approved the acquisition of Sushodha Institute of Gastroenterology Private Limited for a total buyout consideration of ₹15.49 crore, to be settled entirely through a share swap. The company will issue 38.71 lakh equity shares at ₹40 apiece to the target’s shareholders. The board also cleared a rights issue to raise up to ₹210 crore, subject to regulatory and shareholder approvals, a massive capital infusion for the ₹411 crore market-cap healthcare company. Additionally, the board resolved to shift its registered office from Assam to Maharashtra.
Powered by Tijori
Arvaya Healthcare Limited’s board approved the acquisition of Sushodha Institute of Gastroenterology Private Limited for a total buyout consideration of ₹15.49 crore, to be settled entirely through a share swap. The company will issue 38.71 lakh equity shares at ₹40 apiece to the target’s shareholders. The board also cleared a rights issue to raise up to ₹210 crore, subject to regulatory and shareholder approvals, a massive capital infusion for the ₹411 crore market-cap healthcare company. Additionally, the board resolved to shift its registered office from Assam to Maharashtra.
Powered by Tijori
July 17 (Reuters) - Bijoy Hans Ltd BIJH.BO:
GETS ADMINISTRATIVE WARNING LETTER FROM SEBI
Source text: [ID:]
Further company coverage: BIJH.BO
(([email protected];;))
July 17 (Reuters) - Bijoy Hans Ltd BIJH.BO:
GETS ADMINISTRATIVE WARNING LETTER FROM SEBI
Source text: [ID:]
Further company coverage: BIJH.BO
(([email protected];;))
Dec 26 (Reuters) - Bijoy Hans Ltd BIJH.BO:
BIJOY HANS - ISSUANCE OF SHARES WORTH UP TO 56.3 MILLION RUPEES
Source text: ID:nBSE66qMJ0
Further company coverage: BIJH.BO
(([email protected];))
Dec 26 (Reuters) - Bijoy Hans Ltd BIJH.BO:
BIJOY HANS - ISSUANCE OF SHARES WORTH UP TO 56.3 MILLION RUPEES
Source text: ID:nBSE66qMJ0
Further company coverage: BIJH.BO
(([email protected];))
More Micro Cap Ideas
See similar 'Micro' cap companies with recent activity
Promoter Buying
Companies where the promoters are bullish
Capex
Companies investing on expansion
Superstar Investor
Companies where well known investors have invested
Popular questions
- Business
- Financials
- Share Price
- Shareholdings
What does Arvaya Healthcare do?
Arvaya Healthcare Ltd is building an integrated healthcare ecosystem spanning multi-specialty hospitals, diagnostics, preventive care, wellness and health technology solutions. The company aims to deliver accessible, connected and data-driven healthcare.
Who are the competitors of Arvaya Healthcare?
Arvaya Healthcare major competitors are Balgopal Commercial, Vinyl Chemicals (I), Fratelli Vineyards, Aerpace Industries, Sreeleathers, Veritas (India), Mishtann Foods. Market Cap of Arvaya Healthcare is ₹476 Crs. While the median market cap of its peers are ₹461 Crs.
Is Arvaya Healthcare financially stable compared to its competitors?
Arvaya Healthcare seems to be less financially stable compared to its competitors. Altman Z score of Arvaya Healthcare is 3.7 and is ranked 4 out of its 8 competitors.
Does Arvaya Healthcare pay decent dividends?
The company seems to be paying a very low dividend. Investors need to see where the company is allocating its profits. Arvaya Healthcare latest dividend payout ratio is 0% and 3yr average dividend payout ratio is 0%
How has Arvaya Healthcare allocated its funds?
Companies resources are allocated to majorly unproductive assets like Cash & Short Term Investments
How strong is Arvaya Healthcare balance sheet?
Balance sheet of Arvaya Healthcare is strong. It shouldn't have solvency or liquidity issues.
Is the profitablity of Arvaya Healthcare improving?
The profit is oscillating. The profit of Arvaya Healthcare is -₹0.93 Crs for TTM, ₹0.14 Crs for Mar 2025 and -₹0.12 Crs for Mar 2024.
Is the debt of Arvaya Healthcare increasing or decreasing?
Yes, The net debt of Arvaya Healthcare is increasing. Latest net debt of Arvaya Healthcare is ₹8.22 Crs as of Mar-26. This is greater than Mar-25 when it was -₹5.37 Crs.
Is Arvaya Healthcare stock expensive?
Yes, Arvaya Healthcare is expensive. Latest PE of Arvaya Healthcare is 677, while 3 year average PE is 0.0. Also latest EV/EBITDA of Arvaya Healthcare is 860 while 3yr average is 106.
Has the share price of Arvaya Healthcare grown faster than its competition?
Arvaya Healthcare has given better returns compared to its competitors. Arvaya Healthcare has grown at ~199.14% over the last 5yrs while peers have grown at a median rate of 14.25%
Is the promoter bullish about Arvaya Healthcare?
Promoters seem not to be bullish about the company and have been selling shares in the open market. Latest quarter promoter holding in Arvaya Healthcare is 30.62% and last quarter promoter holding is 62.73%
Are mutual funds buying/selling Arvaya Healthcare?
There is Insufficient data to gauge this.